Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends

Q Sun, Z Hong, C Zhang, L Wang, Z Han… - Signal transduction and …, 2023 - nature.com
Abstract Immune-checkpoint inhibitors (ICBs), in addition to targeting CTLA-4, PD-1, and PD-
L1, novel targeting LAG-3 drugs have also been approved in clinical application. With the …

Targeting signaling pathways in prostate cancer: mechanisms and clinical trials

Y He, W Xu, YT Xiao, H Huang, D Gu… - Signal transduction and …, 2022 - nature.com
Prostate cancer (PCa) affects millions of men globally. Due to advances in understanding
genomic landscapes and biological functions, the treatment of PCa continues to improve …

Blocking PD-L1–PD-1 improves senescence surveillance and ageing phenotypes

TW Wang, Y Johmura, N Suzuki, S Omori, T Migita… - Nature, 2022 - nature.com
The accumulation of senescent cells is a major cause of age-related inflammation and
predisposes to a variety of age-related diseases. However, little is known about the …

Eliminating METTL1‐mediated accumulation of PMN‐MDSCs prevents hepatocellular carcinoma recurrence after radiofrequency ablation

X Zeng, G Liao, S Li, H Liu, X Zhao, S Li, K Lei… - Hepatology, 2023 - journals.lww.com
Conclusions: Our study sheds light on the pivotal role of METTL1 in modulating an
immunosuppressive microenvironment and demonstrated that interrupting METTL1‐TGF‐β2 …

Lysine catabolism reprograms tumour immunity through histone crotonylation

H Yuan, X Wu, Q Wu, A Chatoff, E Megill, J Gao… - Nature, 2023 - nature.com
Cancer cells rewire metabolism to favour the generation of specialized metabolites that
support tumour growth and reshape the tumour microenvironment,. Lysine functions as a …

Methionine restriction promotes cGAS activation and chromatin untethering through demethylation to enhance antitumor immunity

L Fang, Y Hao, H Yu, X Gu, Q Peng, H Zhuo, Y Li, Z Liu… - Cancer Cell, 2023 - cell.com
Summary Cyclic GMP-AMP synthase (cGAS) is the major sensor for cytosolic DNA and
activates type I interferon signaling and plays an essential role in antitumor immunity …

CECR2 drives breast cancer metastasis by promoting NF-κB signaling and macrophage-mediated immune suppression

M Zhang, ZZ Liu, K Aoshima, WL Cai, H Sun… - Science translational …, 2022 - science.org
Metastasis is the major cause of cancer-related deaths due to the lack of effective therapies.
Emerging evidence suggests that certain epigenetic and transcriptional regulators drive …

Histone modifications in drug-resistant cancers: From a cancer stem cell and immune evasion perspective

ML Jin, KW Jeong - Experimental & Molecular Medicine, 2023 - nature.com
The development and immune evasion of cancer stem cells (CSCs) limit the efficacy of
currently available anticancer therapies. Recent studies have shown that epigenetic …

Asymmetric distribution of parental H3K9me3 in S phase silences L1 elements

Z Li, S Duan, X Hua, X Xu, Y Li, D Menolfi, H Zhou… - Nature, 2023 - nature.com
In eukaryotes, repetitive DNA sequences are transcriptionally silenced through histone H3
lysine 9 trimethylation (H3K9me3). Loss of silencing of the repeat elements leads to genome …

IL-7R licenses a population of epigenetically poised memory CD8+ T cells with superior antitumor efficacy that are critical for melanoma memory

G Micevic, A Daniels, K Flem-Karlsen… - Proceedings of the …, 2023 - National Acad Sciences
Recurrence of advanced melanoma after therapy is a major risk factor for reduced survival,
and treatment options are limited. Antitumor immune memory plays a critical role in …